ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
0
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,057
similar
All similar
Record
: found
Abstract
: not found
Book Chapter
: not found
Red Book: 2024–2027 Report of the Committee on Infectious Diseases
Staphylococcal Food Poisoning
other
Publication date:
April 25 2024
Publisher:
American Academy of Pediatrics345 Park Blvd, Itasca, IL 60143
Read this book at
Publisher
Further versions
Buy book
Review
Review book
Invite someone to review
Bookmark
Cite as...
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
AHRO Reviews Food Sciences & Nutrition
Author and book information
Book Chapter
Publication date:
April 25 2024
Pages
: 766-767
DOI:
10.1542/9781610027373-S3_018_007
SO-VID:
e3fbfab4-5902-4489-a484-24a07661c2ec
History
Data availability:
Comments
Comment on this book
Sign in to comment
Book chapters
pp. XXXVII
Summary of Major Changes in the 2024 Red Book
pp. 1
Systems-Based Treatment Table
pp. 19
Prologue
pp. 21
Sources of Information About Vaccines and Immunization
pp. 25
Vaccine Uptake: Definitions and Understanding Common Influences of Vaccine Behavior
pp. 27
Understanding Vaccine Evaluation and Safety as an Approach to Addressing Parental Concerns
pp. 32
Evidence-Based Communication Strategies to Increase Uptake of Childhood Vaccines
pp. 36
Policies for Families Who Refuse or Delay Vaccination
pp. 36
Vaccine Injury Compensation
pp. 38
Active Immunization
pp. 42
Vaccine Ingredients
pp. 45
Vaccine Handling and Storage
pp. 52
Vaccine Administration
pp. 57
Managing Injection Pain
pp. 58
Immunization Schedule and Timing of Vaccines
pp. 61
Minimum Ages and Minimum Intervals Between Vaccine Doses
pp. 62
Interchangeability of Vaccine Products
pp. 63
Simultaneous Administration of Multiple Vaccines
pp. 65
Combination Vaccines
pp. 66
Lapsed Immunizations
pp. 67
Unknown or Uncertain Immunization Status
pp. 68
Active Immunization After Receipt of Antibody-Containing Products
pp. 68
Vaccine Dose
pp. 71
Hypersensitivity Reactions After Immunization
pp. 73
Passive Immunization
pp. 74
Immune Globulin Intramuscular (IGIM)
pp. 77
Immune Globulin Intravenous (IGIV)
pp. 82
Immune Globulin Subcutaneous (IGSC)
pp. 84
Treatment of Anaphylactic Reactions
pp. 87
Immunization in Preterm and Low Birth Weight Infants
pp. 89
Immunization in Pregnancy
pp. 93
Immunization and Other Considerations in Immunocompromised Children
pp. 109
Immunization in Children With a Personal or Family History of Seizures
pp. 110
Immunization in Children With Chronic Diseases
pp. 111
Immunization in American Indian/Alaska Native Children and Adolescents
pp. 114
Immunization in Adolescent and College Populations
pp. 115
Immunization in Health Care Personnel
pp. 119
Children Who Received Immunizations Outside the United States or Whose Immunization Status is Unknown or Uncertain
pp. 126
International Travel
pp. 135
AAP Recommendations on Breastfeeding
pp. 135
Breastfeeding and Human Milk
pp. 136
Contraindications to Breastfeeding
pp. 136
Transmission of Infectious Agents via Human Milk
pp. 141
Immunization of Breastfeeding Parents and Infants
pp. 143
Human Milk Banks
pp. 143
Inadvertent Human Milk Exposure
pp. 144
Antimicrobial Agents and Other Drugs in Human Milk
pp. 144
Anti-TNF Biologic Response Modifiers in Human Milk
pp. 145
Children in Group Child Care and Schools
pp. 145
Modes of Spread of Infectious Diseases
pp. 158
Management and Prevention of Infectious Diseases
pp. 163
Infection Prevention and Control for Hospitalized Children
pp. 164
Infection Prevention and Control Precautions
pp. 171
Strategies to Prevent Health Care-Associated Infections
pp. 172
Occupational Health
pp. 173
Sibling Visitation
pp. 174
Pet Visitation
pp. 174
Adult Visitation
pp. 175
Infection Prevention and Control in Ambulatory Settings
pp. 179
Sexually Transmitted Infections in Adolescents and Children
pp. 180
STIs During Preventive Health Care of Adolescents
pp. 182
Sexual Assault and Abuse in Children and Adolescents/Young Adults
pp. 189
Medical Evaluation for Infectious Diseases for Internationally Adopted, Refugee, and Other Immigrant Children,
pp. 190
Internationally Adopted Children
pp. 190
Refugees
pp. 191
Consideration for Testing for Infectious Agents
pp. 191
Immigrants
pp. 198
Injuries From Needles Discarded in the Community
pp. 199
Bloodborne Pathogens
pp. 199
Wound Care and Tetanus Prophylaxis
pp. 201
Preventing Needlestick Injuries
pp. 202
Bite Wounds
pp. 207
Prevention of Mosquito-borne and Tick-borne Infections
pp. 209
General Protective Measures
pp. 211
Repellents for Use on Skin
pp. 213
Tick Inspection and Removal
pp. 214
Other Preventive Measures
pp. 214
Prevention of Illnesses Associated With Recreational Water Use
pp. 216
Control Measures
pp. 218
“Swimmer’s Ear”/Acute Otitis Externa
pp. 221
Actinomycosis
pp. 222
Adenovirus Infections
pp. 225
Amebiasis
pp. 228
Amebic Meningoencephalitis and Keratitis (Naegleria fowleri, Acanthamoeba species, and Balamuthia mandrillaris)
pp. 232
Anthrax
pp. 237
Arboviruses (also see Chikungunya, p 295, Dengue, p 352, West Nile Virus, p 957, and Zika, p 963) (Including Cache Valley, Colorado Tick Fever, Eastern Equine Encephalitis, Heartland, Jamestown Canyon, Japanese Encephalitis, La Crosse, Powassan, St. Louis Encephalitis, Tick-borne Encephalitis, and Yellow Fever Viruses)
pp. 244
Arcanobacterium haemolyticum Infections
pp. 246
Ascaris lumbricoides Infections
pp. 247
Aspergillosis
pp. 252
Astrovirus Infections
pp. 253
Babesiosis
pp. 256
Bacillus cereus Infections and Intoxications
pp. 258
Bacterial Vaginosis
pp. 261
Bacteroides, Prevotella, and Other Anaerobic Gram-Negative Bacilli Infections
pp. 262
Balantidium coli Infections (Balantidiasis)
pp. 263
Bartonella henselae (Cat-Scratch Disease)
pp. 266
Baylisascaris Infections
pp. 268
Infections With Blastocystis Species
pp. 270
Blastomycosis
pp. 272
Bocavirus
pp. 274
Borrelia Infections Other Than Lyme Disease (Relapsing Fever)
pp. 277
Brucellosis
pp. 280
Burkholderia Infections
pp. 283
Campylobacter Infections
pp. 286
Candidiasis
pp. 293
Chancroid and Cutaneous Ulcers
pp. 295
Chikungunya
pp. 298
Chlamydia pneumoniae
pp. 299
Chlamydia psittaci (Psittacosis, Ornithosis, Parrot Fever)
pp. 301
Chlamydia trachomatis
pp. 308
Botulism and Infant Botulism (Clostridium botulinum)
pp. 312
Clostridial Myonecrosis (Gas Gangrene)
pp. 313
Clostridioides difficile (Formerly Clostridium difficile)
pp. 319
Clostridium perfringens Foodborne Illness
pp. 320
Coccidioidomycosis
pp. 324
Coronavirus Disease 2019 (COVID-19)
pp. 332
Coronaviruses, Including MERS-CoV and SARS-CoV-1
pp. 334
Cryptococcus neoformans and Cryptococcus gattii Infections (Cryptococcosis)
pp. 338
Cryptosporidiosis
pp. 341
Cutaneous Larva Migrans
pp. 342
Cyclosporiasis
pp. 343
Cystoisosporiasis (Formerly Isosporiasis)
pp. 344
Cytomegalovirus Infection
pp. 352
Dengue
pp. 357
Diphtheria
pp. 361
Ehrlichia, Anaplasma, and Related Infections (Human Ehrlichiosis, Anaplasmosis, and Related Infections Attributable to Bacteria in the Family Anaplasmataceae)
pp. 365
Serious Neonatal Bacterial Infections Caused by Enterobacterales (Including Septicemia and Meningitis)
pp. 369
Enterovirus (Nonpoliovirus) (Group A and B Coxsackieviruses, Echoviruses, Numbered Enteroviruses)
pp. 372
Epstein-Barr Virus Infections (Infectious Mononucleosis)
pp. 376
Escherichia coli Diarrhea (Including Hemolytic-Uremic Syndrome)
pp. 382
Other Fungal Diseases
pp. 388
Fusobacterium Infections (Including Lemierre Syndrome)
pp. 390
Giardia duodenalis (Formerly Giardia lamblia and Giardia intestinalis) Infections (Giardiasis)
pp. 394
Gonococcal Infections
pp. 399
Granuloma Inguinale (Donovanosis)
pp. 400
Haemophilus influenzae Infections
pp. 409
Hantavirus Pulmonary Syndrome
pp. 412
Helicobacter pylori Infections
pp. 417
Hemorrhagic Fevers Caused by Arenaviruses
pp. 420
Hemorrhagic Fevers Caused by Bunyaviruses
pp. 423
Hemorrhagic Fevers Caused by Filoviruses: Ebola and Marburg
pp. 430
Hepatitis A
pp. 437
Hepatitis B
pp. 458
Hepatitis C
pp. 464
Hepatitis D
pp. 465
Hepatitis E
pp. 467
Herpes Simplex
pp. 478
Histoplasmosis
pp. 482
Hookworm Infections (Necator americanus and Ancylostoma species)
pp. 484
Human Herpesvirus 6 (Including Roseola) and 7
pp. 487
Human Herpesvirus 8
pp. 489
Human Immunodeficiency Virus Infection
pp. 503
Human Papillomaviruses
pp. 511
Influenza
pp. 522
Kawasaki Disease
pp. 529
Kingella kingae Infections
pp. 531
Legionella Infections
pp. 535
Leishmaniasis
pp. 539
Leprosy
pp. 542
Leptospirosis
pp. 545
Listeria monocytogenes Infections (Listeriosis)
pp. 549
Lyme Disease (Lyme Borreliosis, Borrelia burgdorferi sensu lato Infection)
pp. 557
Lymphatic Filariasis (Bancroftian, Malayan, and Timorian)
pp. 559
Lymphocytic Choriomeningitis Virus
pp. 561
Malaria
pp. 570
Measles
pp. 585
Meningococcal Infections
pp. 599
Human Metapneumovirus
pp. 601
Microsporidia Infections (Microsporidiosis)
pp. 603
Molluscum Contagiosum
pp. 604
Moraxella catarrhalis Infections
pp. 606
Mpox
pp. 611
Mumps
pp. 616
Mycoplasma pneumoniae and Other Mycoplasma Species Infections
pp. 620
Nocardiosis
pp. 622
Norovirus and Sapovirus Infections
pp. 624
Onchocerciasis (River Blindness, Filariasis)
pp. 626
Paracoccidioidomycosis (Formerly Known as South American Blastomycosis)
pp. 628
Paragonimiasis
pp. 630
Parainfluenza Viral Infections
pp. 632
Parasitic Diseases
pp. 637
Parechovirus Infections
pp. 638
Parvovirus B19 (Erythema Infectiosum, Fifth Disease)
pp. 642
Pasteurella Infections
pp. 644
Pediculosis Capitis (Head Lice)
pp. 649
Pediculosis Corporis (Body Lice)
pp. 650
Pediculosis Pubis (Pubic Lice, Crab Lice)
pp. 652
Pelvic Inflammatory Disease
pp. 656
Pertussis (Whooping Cough)
pp. 667
Pinworm Infection (Enterobius vermicularis)
pp. 669
Pityriasis Versicolor (Formerly Tinea Versicolor)
pp. 671
Plague
pp. 676
Pneumocystis jirovecii Infections
pp. 682
Poliovirus Infections
pp. 689
Polyomaviruses (BK, JC, and Other Polyomaviruses)
pp. 692
Prion Diseases: Transmissible Spongiform Encephalopathies
pp. 697
Pseudomonas aeruginosa Infections
pp. 699
Q Fever (Coxiella burnetii Infection)
pp. 702
Rabies
pp. 711
Rat-Bite Fever
pp. 713
Respiratory Syncytial Virus
pp. 721
Rhinovirus Infections
pp. 723
Rickettsial Diseases
pp. 726
Rickettsialpox
pp. 727
Rocky Mountain Spotted Fever
pp. 730
Rotavirus Infections
pp. 735
Rubella
pp. 742
Salmonella Infections
pp. 750
Scabies
pp. 753
Schistosomiasis
pp. 756
Shigella Infections
pp. 760
Smallpox (Variola)
pp. 764
Sporotrichosis
pp. 766
Staphylococcal Food Poisoning
pp. 767
Staphylococcus aureus
pp. 782
Coagulase-Negative Staphylococcal Infections
pp. 785
Group A Streptococcal Infections
pp. 799
Group B Streptococcal Infections
pp. 806
Non-Group A or B Streptococcal and Enterococcal Infections
pp. 810
Streptococcus pneumoniae (Pneumococcal) Infections
pp. 822
Strongyloidiasis (Strongyloides stercoralis)
pp. 825
Syphilis
pp. 842
Tapeworm Diseases (Taeniasis and Cysticercosis)
pp. 845
Other Tapeworm Infections (Including Hydatid Disease)
pp. 848
Tetanus (Lockjaw)
pp. 854
Tinea Capitis (Ringworm of the Scalp)
pp. 858
Tinea Corporis (Ringworm of the Body)
pp. 861
Tinea Cruris (Jock Itch)
pp. 863
Tinea Pedis and Tinea Unguium (Onychomycosis) (Athlete’s Foot, Ringworm of the Feet)
pp. 865
Toxocariasis
pp. 867
Toxoplasma gondii Infections (Toxoplasmosis)
pp. 875
Trichinellosis (Trichinella spiralis and Other Species)
pp. 877
Trichomonas vaginalis Infections (Trichomoniasis)
pp. 880
Trichuriasis (Whipworm Infection)
pp. 881
African Trypanosomiasis (Sleeping Sickness)
pp. 884
American Trypanosomiasis (Chagas Disease)
pp. 888
Tuberculosis
pp. 920
Nontuberculous Mycobacteria (Environmental Mycobacteria, Mycobacteria Other Than Mycobacterium tuberculosis)
pp. 929
Tularemia
pp. 932
Louse-borne Typhus (Epidemic or Sylvatic Typhus)
pp. 934
Murine Typhus (Endemic or Flea-borne Typhus)
pp. 936
Ureaplasma urealyticum and Ureaplasma parvum Infections
pp. 938
Varicella-Zoster Virus Infections
pp. 952
Cholera (Vibrio cholerae)
pp. 955
Other Vibrio Infections
pp. 957
West Nile Virus
pp. 960
Yersinia enterocolitica and Yersinia pseudotuberculosis Infections (Enteritis and Other Illnesses)
pp. 963
Zika
pp. 973
Introduction
pp. 973
Fluoroquinolones
pp. 975
Tetracyclines
pp. 976
Beta-lactam and Monobactam Allergies,
pp. 976
Antimicrobial Agents Approved for Use in Adults but Not Children
pp. 978
Antimicrobial Resistance
pp. 979
Factors Contributing to Resistance
pp. 980
Actions to Prevent or Slow Antimicrobial Resistance
pp. 981
Antimicrobial Stewardship
pp. 983
Role of the Clinician
pp. 984
Principles of Appropriate Use of Antimicrobial Therapy for Upper Respiratory Tract Infections
pp. 987
Tables of Antibacterial Drug Dosages
pp. 1007
Sexually Transmitted Infections
pp. 1017
Polyenes
pp. 1017
Antifungal Drugs for Systemic Fungal Infections
pp. 1018
Pyrimidines
pp. 1018
Azoles
pp. 1020
Triterpenoids
pp. 1020
Echinocandins
pp. 1026
Recommended Doses of Parenteral and Oral Antifungal Drugs
pp. 1037
Topical Drugs for Superficial Fungal Infections
pp. 1044
Non-HIV Antiviral Drugs
pp. 1068
Drugs for Parasitic Infections
pp. 1113
MedWatch—The FDA Safety Information and Adverse Event Reporting Program
pp. 1114
Infection-Prone Body Sites
pp. 1114
Antimicrobial Prophylaxis
pp. 1116
Vulnerable Hosts
pp. 1116
Prophylaxis Following Exposure to Specific Pathogens
pp. 1117
Indications for Prophylaxis
pp. 1117
Guidelines for Appropriate Use
pp. 1117
Antimicrobial Prophylaxis in Pediatric Surgical Patients
pp. 1119
Surgical Site Infection Criteria
pp. 1120
Dosing and Duration of Administration of Antimicrobial Agents
pp. 1120
Timing of Administration of Prophylactic Antimicrobial Agents
pp. 1121
Preoperative Screening and Decolonization
pp. 1121
Recommended Antimicrobial Agents
pp. 1127
Prevention of Bacterial Endocarditis
pp. 1129
Neonatal Ophthalmia Prevention
pp. 1129
Primary Prevention
pp. 1131
Secondary Prevention
pp. 1132
Legal Mandates for Topical Prophylaxis for Neonatal Ophthalmia
pp. 1132
Pseudomonal Ophthalmia Neonatorum
pp. 1133
Other Nongonococcal, Nonchlamydial Ophthalmia
pp. 1134
Directory of Resources
pp. 1139
Codes for Commonly Administered Pediatric Vaccines, Toxoids, and Immune Globulins
pp. 1141
Nationally Notifiable Infectious Diseases in the United States
pp. 1144
Guide to Contraindications and Precautions to Immunizations
pp. 1145
Prevention of Infectious Disease From Contaminated Food Products
pp. 1150
Clinical Syndromes Associated With Foodborne Diseases,
pp. 1157
Diseases Transmitted by Animals (Zoonoses)
Similar content
2,057
Case Report: Delayed recurrence of staphylococcal scalded skin syndrome in an extremely low birth weight infant
Authors:
Sara M. Hooper
,
Camille M. Fung
,
Carrie Torr
…
Comparative Genomic Analysis of Staphylococcal Cassette Chromosome mec Type V Staphylococcus aureus Strains and Estimation of the Emergence of SCC mec V Clinical Isolates in Korea
Authors:
Takashi Takahashi
,
Hyaekang Kim
,
Han-Sung Kim
…
In vitro evaluation of anti-staphylococcal activity of Ganoderma lucidum, Ganoderma praelongum and Ganoderma resinaceum from Pune, India
Authors:
A Améri
,
J.G. Vaidya
,
S.S. Deokule
…
See all similar